NFKB1 and chronic obstructive pulmonary disease: NF-κB activation in asthma and COPD occurs largely in response to inflammatory mediators such as interleukin (IL)-1β and tumour necrosis factor (TNF)-α or elicited by the activation of toll like receptors (TLRs) during bacterial or viral-exacerbation [15].